血流增强搭桥手术：适应症和决策。

Q2 Medicine

Acta neurochirurgica. Supplement Pub Date : 2025-01-01 DOI:10.1007/978-3-031-89844-0_14

Giuseppe Esposito, Martina Sebök, Jorn Fierstra, Luca Regli

{"title":"血流增强搭桥手术：适应症和决策。","authors":"Giuseppe Esposito, Martina Sebök, Jorn Fierstra, Luca Regli","doi":"10.1007/978-3-031-89844-0_14","DOIUrl":null,"url":null,"abstract":"Flow-augmentation bypass aims to enhance blood flow to hypoperfused brain regions in patients with cerebrovascular steno-occlusive diseases. This surgical procedure is indicated for ischemic and hemorrhagic moyamoya vasculopathy and for selected patients with chronic steno-occlusive disease and acute ischemic stroke. Flow-augmentation bypass has been rigorously evaluated in randomized clinical trials, including the EC-IC Bypass Trial, the Carotid Occlusion Surgery Study (COSS), the Japanese Adult Moyamoya (JAM) trial, and the recent Carotid and Middle Cerebral Artery Occlusion Surgery Study (CMOSS). In this article, we examine the current indications and outline the diagnostic and therapeutic decision-making processes for patients with steno-occlusive disease who are candidates for flow-augmentation bypass surgery.","PeriodicalId":6913,"journal":{"name":"Acta neurochirurgica. Supplement","volume":"136 ","pages":"113-118"},"PeriodicalIF":0.0000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Flow-Augmentation Bypass Surgery: Indications and Decision-Making.\",\"authors\":\"Giuseppe Esposito, Martina Sebök, Jorn Fierstra, Luca Regli\",\"doi\":\"10.1007/978-3-031-89844-0_14\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Flow-augmentation bypass aims to enhance blood flow to hypoperfused brain regions in patients with cerebrovascular steno-occlusive diseases. This surgical procedure is indicated for ischemic and hemorrhagic moyamoya vasculopathy and for selected patients with chronic steno-occlusive disease and acute ischemic stroke. Flow-augmentation bypass has been rigorously evaluated in randomized clinical trials, including the EC-IC Bypass Trial, the Carotid Occlusion Surgery Study (COSS), the Japanese Adult Moyamoya (JAM) trial, and the recent Carotid and Middle Cerebral Artery Occlusion Surgery Study (CMOSS). In this article, we examine the current indications and outline the diagnostic and therapeutic decision-making processes for patients with steno-occlusive disease who are candidates for flow-augmentation bypass surgery.\",\"PeriodicalId\":6913,\"journal\":{\"name\":\"Acta neurochirurgica. Supplement\",\"volume\":\"136 \",\"pages\":\"113-118\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Acta neurochirurgica. Supplement\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1007/978-3-031-89844-0_14\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta neurochirurgica. Supplement","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/978-3-031-89844-0_14","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

摘要

血流增强搭桥术的目的是在脑血管狭窄闭塞性疾病患者中增强低灌注脑区的血流量。该手术适用于缺血性和出血性烟雾病，以及慢性狭窄闭塞疾病和急性缺血性中风的特定患者。血流增强搭桥在随机临床试验中得到了严格的评估，包括EC-IC搭桥试验、颈动脉闭塞手术研究（COSS）、日本成人Moyamoya （JAM）试验和最近的颈动脉和大脑中动脉闭塞手术研究（CMOSS）。在这篇文章中，我们研究了目前的适应症，并概述了狭窄闭塞性疾病患者进行血流增强搭桥手术的诊断和治疗决策过程。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Flow-Augmentation Bypass Surgery: Indications and Decision-Making.

Flow-augmentation bypass aims to enhance blood flow to hypoperfused brain regions in patients with cerebrovascular steno-occlusive diseases. This surgical procedure is indicated for ischemic and hemorrhagic moyamoya vasculopathy and for selected patients with chronic steno-occlusive disease and acute ischemic stroke. Flow-augmentation bypass has been rigorously evaluated in randomized clinical trials, including the EC-IC Bypass Trial, the Carotid Occlusion Surgery Study (COSS), the Japanese Adult Moyamoya (JAM) trial, and the recent Carotid and Middle Cerebral Artery Occlusion Surgery Study (CMOSS). In this article, we examine the current indications and outline the diagnostic and therapeutic decision-making processes for patients with steno-occlusive disease who are candidates for flow-augmentation bypass surgery.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Acta neurochirurgica. Supplement Medicine-Surgery

CiteScore

1.90

自引率

0.00%

发文量

期刊介绍： In addition to the regular journal, "Acta Neurochirurgica" publishes 3-4 supplement volumes per year. These comprise proceedings of international meetings or other material of general neurosurgical interest.